Quality Care

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.

Dr. Baligh Yehia, Jefferson Health's president, says the health system will use AI to streamline scheduling, tackle revenue cycle challenges, close care gaps and give clinicians back 10 million patient hours over the next three years.

Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.

Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.

Atropos Health CEO, Brigham Hyde, discusses the integration of Atropos' agentic AI agent into Microsoft Teams, helping clinical teams analyze patient information and clinical documentation during team meetings to support decision making.

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.

According to Kevin Ritter of Altera Digital Health, health systems must go beyond simple information exchange to ensure their data is discrete, normalized and able to flow between multiple applications across the enterprise.

HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.